Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains

HMB. Seth-Smith, A. Bénard, SM. Bruisten, B. Versteeg, B. Herrmann, J. Kok, I. Carter, O. Peuchant, C. Bébéar, DA. Lewis, T. Puerta, D. Keše, E. Balla, H. Zákoucká, F. Rob, SA. Morré, B. de Barbeyrac, JC. Galán, HJC. de Vries, NR. Thomson, D....

. 2021 ; 7 (6) : . [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004278

Lymphogranuloma venereum (LGV), the invasive infection of the sexually transmissible infection (STI) Chlamydia trachomatis, is caused by strains from the LGV biovar, most commonly represented by ompA-genotypes L2b and L2. We investigated the diversity in LGV samples across an international collection over seven years using typing and genome sequencing. LGV-positive samples (n=321) from eight countries collected between 2011 and 2017 (Spain n=97, Netherlands n=67, Switzerland n=64, Australia n=53, Sweden n=37, Hungary n=31, Czechia n=30, Slovenia n=10) were genotyped for pmpH and ompA variants. All were found to contain the 9 bp insertion in the pmpH gene, previously associated with ompA-genotype L2b. However, analysis of the ompA gene shows ompA-genotype L2b (n=83), ompA-genotype L2 (n=180) and several variants of these (n=52; 12 variant types), as well as other/mixed ompA-genotypes (n=6). To elucidate the genomic diversity, whole genome sequencing (WGS) was performed from selected samples using SureSelect target enrichment, resulting in 42 genomes, covering a diversity of ompA-genotypes and representing most of the countries sampled. A phylogeny of these data clearly shows that these ompA-genotypes derive from an ompA-genotype L2b ancestor, carrying up to eight SNPs per isolate. SNPs within ompA are overrepresented among genomic changes in these samples, each of which results in an amino acid change in the variable domains of OmpA (major outer membrane protein, MOMP). A reversion to ompA-genotype L2 with the L2b genomic backbone is commonly seen. The wide diversity of ompA-genotypes found in these recent LGV samples indicates that this gene is under immunological selection. Our results suggest that the ompA-genotype L2b genomic backbone is the dominant strain circulating and evolving particularly in men who have sex with men (MSM) populations.

Amsterdam UMC University of Amsterdam Amsterdam Institute for Infection and Immunity Location Academic Medical Centre Amsterdam The Netherlands

Applied Microbiology Research Department of Biomedicine University of Basel Basel Switzerland

Bacterial STI Reference Laboratory National Public Health Center Budapest Hungary

Centre for Infectious Diseases and Microbiology Laboratory Services Institute of Clinical Pathology and Medical Research Westmead Hospital Westmead New South Wales Australia

CHU Bordeaux Department of Bacteriology French National Reference Center for bacterial STIs Bordeaux France

Clinical Bacteriology and Mycology University Hospital Basel University of Basel Switzerland

Clinical Research Department London School of Hygiene and Tropical Medicine London UK

Department of Dermatovenereology 2nd Faculty of Medicine Charles University and Hospital Bulovka Budinova 2 180 81 Prague 8 Czech Republic

Department of Infectious Diseases GGD Public Health Service of Amsterdam Amsterdam The Netherlands

Institute for Public Health Genomics Department of Genetics and Cell Biology Research Institute GROW University of Maastricht Maastricht The Netherlands

Laboratory of Immunogenetics Department of Medical Microbiology and Infection Control VU University Medical Center Amsterdam Amsterdam The Netherlands

Marie Bashir Institute for Infectious Diseases and Biosecurity and Westmead Clinical School University of Sydney Sydney New South Wales Australia

National Reference Laboratory for Diagnostics of Syphilis and Chlamydia Infections National Institute of Public Health Srobarova 48 100 42 Prague 10 Czech Republic

Present address Healthcare Systems Research Group VHIR Universitat Autònoma de Barcelona Passeig de la Vall d'Hebron 119 129 08035 Barcelona Spain

Section of Clinical Bacteriology Department of Medical Sciences Uppsala University Uppsala Sweden

Servicio de Microbiología Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal de Investigación Sanitaria

SIB Swiss Institute of Bioinformatics Basel Switzerland

Unidad de ITS VIH Centro Sanitario Sandoval Hospital Clínico San Carlos Instituto de Investigación Sanitaria San Carlos Madrid Spain

University of Ljubljana Faculty of Medicine Institute of Microbiology and Immunology Ljubljana Slovenia

Wellcome Trust Sanger Institute Cambridge UK

Western Sydney Sexual Health Centre Western Sydney Local Health District Parramatta New South Wales Australia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004278
003      
CZ-PrNML
005      
20220127145401.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1099/mgen.0.000599 $2 doi
035    __
$a (PubMed)34184981
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Seth-Smith, Helena M B $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland $u Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland $u SIB Swiss Institute of Bioinformatics, Basel, Switzerland
245    10
$a Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains / $c HMB. Seth-Smith, A. Bénard, SM. Bruisten, B. Versteeg, B. Herrmann, J. Kok, I. Carter, O. Peuchant, C. Bébéar, DA. Lewis, T. Puerta, D. Keše, E. Balla, H. Zákoucká, F. Rob, SA. Morré, B. de Barbeyrac, JC. Galán, HJC. de Vries, NR. Thomson, D. Goldenberger, A. Egli
520    9_
$a Lymphogranuloma venereum (LGV), the invasive infection of the sexually transmissible infection (STI) Chlamydia trachomatis, is caused by strains from the LGV biovar, most commonly represented by ompA-genotypes L2b and L2. We investigated the diversity in LGV samples across an international collection over seven years using typing and genome sequencing. LGV-positive samples (n=321) from eight countries collected between 2011 and 2017 (Spain n=97, Netherlands n=67, Switzerland n=64, Australia n=53, Sweden n=37, Hungary n=31, Czechia n=30, Slovenia n=10) were genotyped for pmpH and ompA variants. All were found to contain the 9 bp insertion in the pmpH gene, previously associated with ompA-genotype L2b. However, analysis of the ompA gene shows ompA-genotype L2b (n=83), ompA-genotype L2 (n=180) and several variants of these (n=52; 12 variant types), as well as other/mixed ompA-genotypes (n=6). To elucidate the genomic diversity, whole genome sequencing (WGS) was performed from selected samples using SureSelect target enrichment, resulting in 42 genomes, covering a diversity of ompA-genotypes and representing most of the countries sampled. A phylogeny of these data clearly shows that these ompA-genotypes derive from an ompA-genotype L2b ancestor, carrying up to eight SNPs per isolate. SNPs within ompA are overrepresented among genomic changes in these samples, each of which results in an amino acid change in the variable domains of OmpA (major outer membrane protein, MOMP). A reversion to ompA-genotype L2 with the L2b genomic backbone is commonly seen. The wide diversity of ompA-genotypes found in these recent LGV samples indicates that this gene is under immunological selection. Our results suggest that the ompA-genotype L2b genomic backbone is the dominant strain circulating and evolving particularly in men who have sex with men (MSM) populations.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a proteiny vnější bakteriální membrány $x genetika $7 D001425
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a Chlamydia trachomatis $x klasifikace $x genetika $7 D002692
650    12
$a molekulární evoluce $7 D019143
650    12
$a genomika $7 D023281
650    _2
$a genotyp $7 D005838
650    _2
$a homosexualita mužská $7 D018451
650    _2
$a lidé $7 D006801
650    _2
$a lymphogranuloma venereum $x epidemiologie $x mikrobiologie $7 D008219
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a molekulární epidemiologie $7 D017720
650    _2
$a fylogeneze $7 D010802
650    _2
$a sekvenční analýza $7 D017421
650    _2
$a sexuální a genderové menšiny $7 D000072339
650    _2
$a sexuálně přenosné nemoci $x mikrobiologie $7 D012749
650    _2
$a sekvenování celého genomu $7 D000073336
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Austrálie $x epidemiologie $7 D001315
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bénard, Angèle $u Present address: Healthcare Systems Research Group, VHIR, Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain $u Wellcome Trust Sanger Institute, Cambridge, UK
700    1_
$a Bruisten, Sylvia M $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity (AII), Location Academic Medical Centre, Amsterdam, The Netherlands
700    1_
$a Versteeg, Bart $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
700    1_
$a Herrmann, Björn $u Section of Clinical Bacteriology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
700    1_
$a Kok, Jen $u Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia $u Marie Bashir Institute for Infectious Diseases and Biosecurity & Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
700    1_
$a Carter, Ian $u Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia
700    1_
$a Peuchant, Olivia $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
700    1_
$a Bébéar, Cécile $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
700    1_
$a Lewis, David A $u Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, New South Wales, Australia $u Marie Bashir Institute for Infectious Diseases and Biosecurity & Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
700    1_
$a Puerta, Teresa $u Unidad de ITS/VIH, Centro Sanitario Sandoval, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
700    1_
$a Keše, Darja $u University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia
700    1_
$a Balla, Eszter $u Bacterial STI Reference Laboratory, National Public Health Center (former National Center for Epidemiology), Budapest, Hungary
700    1_
$a Zákoucká, Hana $u National Reference Laboratory for Diagnostics of Syphilis and Chlamydia Infections, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic
700    1_
$a Rob, Filip $u Department of Dermatovenereology, Second Faculty of Medicine, Charles University and Hospital Bulovka, Budinova 2, 180 81, Prague 8, Czech Republic
700    1_
$a Morré, Servaas A $u Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center Amsterdam, Amsterdam, The Netherlands $u Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research Institute GROW, University of Maastricht, Maastricht, The Netherlands
700    1_
$a de Barbeyrac, Bertille $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
700    1_
$a Galán, Juan Carlos $u Servicio de Microbiología, Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. CIBER en Epidemiología y Salud Pública (CIBERESP)
700    1_
$a de Vries, Henry J C $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity (AII), Location Academic Medical Centre, Amsterdam, The Netherlands
700    1_
$a Thomson, Nicholas R $u Wellcome Trust Sanger Institute, Cambridge, UK $u Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
700    1_
$a Goldenberger, Daniel $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland
700    1_
$a Egli, Adrian $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland $u Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
773    0_
$w MED00208694 $t Microbial genomics $x 2057-5858 $g Roč. 7, č. 6 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34184981 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145357 $b ABA008
999    __
$a ok $b bmc $g 1751674 $s 1155427
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 6 $e - $i 2057-5858 $m Microbial genomics $n Microb Genom $x MED00208694
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...